85
Views
6
CrossRef citations to date
0
Altmetric
Original

Peripheral blood T lymphocyte sensitisation against calsequestrin and flavoprotein in patients with Graves' ophthalmopathy

, , , &
Pages 372-376 | Received 24 Oct 2007, Accepted 08 Jan 2008, Published online: 07 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Hooshang Lahooti, Daniele Cultrone, Senarath Edirimanne, John P Walsh, Leigh Delbridge, Patrick Cregan, Bernard Champion & Jack R Wall. (2015) Novel single-nucleotide polymorphisms in the calsequestrin-1 gene are associated with Graves’ ophthalmopathy and Hashimoto’s thyroiditis. Clinical Ophthalmology 9, pages 1731-1740.
Read now
Hooshang Lahooti, Kishan R Parmar & Jack R Wall. (2010) Pathogenesis of thyroid-associated ophthalmopathy: does autoimmunity against calsequestrin and collagen XIII play a role?. Clinical Ophthalmology 4, pages 417-425.
Read now

Articles from other publishers (4)

Joachim Neumann, Konrad Bödicker, Igor B. Buchwalow, Constanze Schmidbaur, Gustavo Ramos, Stefan Frantz, Ulrich Hofmann & Ulrich Gergs. (2022) Effects of acute ischemia and hypoxia in young and adult calsequestrin (CSQ2) knock-out and wild-type mice. Molecular and Cellular Biochemistry 477:6, pages 1789-1801.
Crossref
B Sun, Z Zhang, C Dong, Y Zhang, C Yan & S Li. (2017) 99Tcm-octreotide scintigraphy and serum eye muscle antibodies in evaluation of active thyroid-associated ophthalmopathy. Eye 31:5, pages 668-676.
Crossref
Leon Wescombe, Hooshang Lahooti, Bamini Gopinath & Jack R. Wall. (2009) The cardiac calsequestrin gene ( CASQ2 ) is up‐regulated in the thyroid in patients with Graves’ ophthalmopathy – support for a role of autoimmunity against calsequestrin as the triggering event . Clinical Endocrinology 73:4, pages 522-528.
Crossref
. (2009) Current World Literature. Current Opinion in Allergy & Clinical Immunology 9:5, pages 482-488.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.